Neurology/psychiatric

RSS

Potent alpha2-adrenoceptor blockers prepared by Pierre Fabre

Oct. 16, 1997

Dose-dependent pain relief with Quadramet in breast and prostate cancer patients

Oct. 16, 1997

SmithKline Beecham launches ReQuip in the U.S.

Oct. 15, 1997

Feasibility of OROS melatonin delivery evaluated in humans

Oct. 15, 1997

Schering AG presents AMPA antagonists

Oct. 15, 1997

MS&D develops subtype-selective 5-HT1D receptor agonists for migraine

Oct. 15, 1997

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Role for NGF in Alzheimer's disease?

Oct. 14, 1997

Pierre Fabre discloses potent and selective 5-HT1B receptor antagonists

Oct. 14, 1997

Briana Bio-Tech licenses peptide technology for chronic MS

Oct. 13, 1997